Literature DB >> 23571704

The impact of body mass index on esophageal cancer.

Joyce Y Wong1, Ravi Shridhar, Khaldoun Almhanna, Sarah E Hoffe, Richard C Karl, Kenneth L Meredith.   

Abstract

BACKGROUND: Surgeons are increasingly operating on patients who are overweight or obese. The influence of obesity on surgical and oncologic outcomes has only recently been addressed. We focus this review on obesity and its impact on esophageal cancer.
METHODS: Recent literature and our own institutional experience were reviewed to determine the impact of body mass index on the perioperative and long-term outcomes of patients with esophageal cancer.
RESULTS: With few exceptions, no significant differences were seen in perioperative outcomes or survival in patients treated for esophageal cancer when stratified by body mass index.
CONCLUSIONS: Although obesity poses increased operative challenges to the surgeon, surgical and oncologic outcomes remain unchanged in obese patients compared with patients who are not obese.

Entities:  

Mesh:

Year:  2013        PMID: 23571704     DOI: 10.1177/107327481302000207

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  7 in total

1.  Comparison of the prognostic values of various nutritional parameters in patients with esophageal squamous cell carcinoma from Southern China.

Authors:  Peng Sun; Fei Zhang; Cui Chen; Xin An; Yu-Hong Li; Feng-Hua Wang; Zhi-Hua Zhu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?

Authors:  Toine M Lodewick; Thiemo J A van Nijnatten; Ronald M van Dam; Kim van Mierlo; Simon A W G Dello; Ulf P Neumann; Steven W M Olde Damink; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2014-12-16       Impact factor: 3.647

3.  Post-discharge complications after esophagectomy account for high readmission rates.

Authors:  Sophia Y Chen; Daniela Molena; Miloslawa Stem; Benedetto Mungo; Anne O Lidor
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

4.  Novel evidence of obesity paradox in esophageal adenocarcinoma: perspective on genes that uncouple adiposity from dismal outcomes.

Authors:  Lei Zhu; Fugui Yang; Lin Dong; Guangxue Wang; Qinchuan Li; Chunlong Zhong
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

5.  Comparison of survival outcomes between transthoracic and transabdominal surgical approaches in patients with Siewert-II/III esophagogastric junction adenocarcinoma: a single-institution retrospective cohort study.

Authors:  Weihan Zhang; Xinzu Chen; Kai Liu; Kun Yang; Xiaolong Chen; Ying Zhao; Yongfan Zhao; Jiaping Chen; Longqi Chen; Jiankun Hu
Journal:  Chin J Cancer Res       Date:  2016-08       Impact factor: 5.087

6.  Body mass index and risk of upper gastrointestinal cancer: A 30-year follow-up of the Linxian dysplasia nutrition intervention trial cohort.

Authors:  Su Zhang; Jian-Bing Wang; Huan Yang; Jin-Hu Fan; You-Lin Qiao; Philip R Taylor
Journal:  Cancer Epidemiol       Date:  2020-02-09       Impact factor: 2.984

7.  Does Preoperative Low HbA1c Predict Esophageal Cancer Outcomes?

Authors:  Ryosuke Kochi; Takashi Suzuki; Satoshi Yajima; Yoko Oshima; Masaaki Ito; Kimihiko Funahashi; Hideaki Shimada
Journal:  Ann Thorac Cardiovasc Surg       Date:  2019-10-30       Impact factor: 1.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.